Background: The ceramide- and phospholipid-based cardiovascular risk score (CERT2) has been found to predict the risk for cardiovascular disease (CVD) events, especially cardiovascular mortality. In the present study, our aim was to estimate the predictive ability of CERT2 for mortality of CVD, coronary artery disease (CAD), and stroke in the elderly and to compare these results with those of conventional lipids.
Methods: We conducted a prospective study with an 18-year follow-up period that included a total of 1260 participants ages ≥64 years.
Objectives: To evaluate the effects of a multifactorial fall prevention program on falls and to identify the subgroups that benefit the most.
Design: Randomized controlled trial.
Setting: Community-dwelling subjects who had fallen at least once during the previous 12 months.
Background: Measuring quality of life (QOL) is an important part in assessing the effects of treatments and health services on patients' well-being. This kind of an assessment should be included when assessing the effects of preventive programmes. The aim was to explore whether QOL has been used as an outcome measure in fall prevention trials and to provide a systematic review of randomized controlled trials (RCTs) that involve fall prevention interventions with an assessment of the effects on QOL among the aged.
View Article and Find Full Text PDF